Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 3/20 | 0.36 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29365026 | 1.00 | CTDSP1 (0.36) | CTDSP1APOBEC3AAPOBEC3GL3MBTL1LMNA | |
| SCHEMBL30754386 | 1.00 | CTDSP1 (0.36) | CTDSP1APOBEC3AAPOBEC3GL3MBTL1LMNA | |
| SCHEMBL31338805 | 1.00 | CTDSP1 (0.36) | CTDSP1APOBEC3AAPOBEC3GL3MBTL1LMNA | |
| SCHEMBL16779993 | 1.00 | CTDSP1 (0.36) | CTDSP1APOBEC3AAPOBEC3GL3MBTL1LMNA | |
| SCHEMBL11810368 | 0.85 | CTDSP1 (0.39) | CTDSP1APOBEC3AAPOBEC3GL3MBTL1LMNA | |
| Methyl Alcohol SCHEMBL1155257 | 0.80 | CTDSP1 (0.43) | CTDSP1APOBEC3AAPOBEC3GL3MBTL1LMNA | |
| SCHEMBL1024401 | 0.79 | — | — | |
| SCHEMBL221719 | 0.74 | CTDSP1 (0.37) | CTDSP1APOBEC3AAPOBEC3GLMNASIGMAR1 | |
| SCHEMBL14867338 | 0.74 | CTDSP1 (0.37) | CTDSP1APOBEC3AAPOBEC3GLMNASIGMAR1 | |
| Acetic Acid SCHEMBL189531 | 0.73 | CTDSP1 (0.38) | CTDSP1APOBEC3AAPOBEC3GL3MBTL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| JP-3024198-A | — | — | None | — | — | JP | disclosed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | disclosed |
| US-11802258-B2 | Perfume precursor | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-10-31 | — | — | US | disclosed |
| US-20210214644-A1 | PERFUME PRECURSOR | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| EP-3689849-A1 | PERFUME PRECURSOR | Takasago International Corporation (JP) | 2020-08-05 | — | — | EP | disclosed |
| JP-H0324198-A | PERFUME COMPOSITION AND BLEACHING AGENT COMPOSITION | TAKASAGO INTERNATL CORP | 1991-02-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802258-B2 | Perfume precursor | CYP2E1, ADH1A, CYP1A1 | CTDSP1 551/4885APOBEC3A 4494/4885APOBEC3G 4658/4885 |
| US-20210214644-A1 | PERFUME PRECURSOR | CYP2E1, ADH1A, CYP1A1 | CTDSP1 551/4885APOBEC3A 4494/4885APOBEC3G 4658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.